Display Settings:

Format

Send to:

Choose Destination
    Nat Rev Cancer. 2003 Aug;3(8):582-91.

    The emerging role of lysophosphatidic acid in cancer.

    Source

    MD Anderson Cancer Center, Houston, Texas 77030, USA. gmills@mdanderson.org

    Abstract

    The bioactive phospholipid lysophosphatidic acid (LPA) stimulates cell proliferation, migration and survival by acting on its cognate G-protein-coupled receptors. Aberrant LPA production, receptor expression and signalling probably contribute to cancer initiation, progression and metastasis. The recent identification of ecto-enzymes that mediate the production and degradation of LPA, as well as the development of receptor-selective analogues, indicate mechanisms by which LPA production or action could be modulated for cancer therapy.

    PMID:
    12894246
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk